302967-61-9Relevant academic research and scientific papers
SALTS OF PYRROLOTRIAZINE DERIVATIVES USEFUL AS TAM INHIBITORS
-
, (2019/04/26)
The present application provides salt forms of N-(4-(4-Amino-7-(1- isobutyrylpiperidin-4-yl)pyrrolo[1,2-f][1,2,4]triazin-5-yl)phenyl)-1- isopropyl-2,4-dioxo-3-(pyridin-2-yl)-1,2,3,4-tetrahydropyrimidine-5- carboxamide (I) and N-(4-(4-Amino-7-(1-isobutyryl
URACIL DERIVATIVES AS MER-AXL INHIBITORS
-
, (2019/11/19)
The invention relates generally to compounds that are Mer-Axl inhibitors, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.
PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS
-
, (2017/10/13)
This application relates to compounds of Formula I: or pharmaceutically acceptable salts thereof, which are inhibitors of TAM kinases which are useful for the treatment of disorders such as cancer.
URACIL DERIVATIVES AS AXL AND C-MET KINASE INHIBITORS
-
Page/Page column 96-97, (2013/06/05)
The present invention provides compounds of Formula I, or pharmaceutically acceptable salt forms thereof, wherein Ra, Rb, Rc, Rd, D, W, R1a, R1b, R1c,Y, R3, X, E and G are as defined herein, methods of treatment and uses thereof.
